Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Icaritin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107641621B reveals a dual-enzyme method for Icaritin. Achieve 98.3% conversion with thermostable glycosidases for cost-effective manufacturing.
Patent CN114539044B enables high-yield Anhydroicaritin production. Novel route ensures purity and supply chain stability for global pharmaceutical manufacturers.